About Vaasavaa Pharmaceuticals Private Limited
Data last updated:
Vaasavaa Pharmaceuticals Private Limited is a private limited company based in Solapur, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 17 July 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2000PTC015122. Its GSTIN is 27AABCV5177B1ZE (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.42 Cr. It is led by directors including Narasimha Rao Polavarapu and Murali Krishna Prasad Koneru.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No C – 216 MIDC Chincholiarea, Solapur, Maharashtra, India – 413255.
As per the financials filed for FY 2025, the company reported a revenue of ₹59.28 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹1.79 Cr (net margin 3%) and EBITDA of ₹4.85 Cr (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 10% over five years.
The company has about 67 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vaasavaa Pharmaceuticals. As per MCA filings, the company has open charges of ₹9.61 Cr and satisfied charges of ₹13.5 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vaasavaa.com.
Company details
Contact details
Vaasavaa Pharmaceuticals Private Limited's registered office is in Solapur, Maharashtra. Its website is vaasavaa.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No C – 216 MIDC Chincholiarea, Solapur, Maharashtra, India – 413255
- IndustryPharma, API Manufacturers
To see the full contact details of Vaasavaa Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Vaasavaa Pharmaceuticals operates one associated brand: Vaasavaa Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures Active Pharmaceutical Ingredients and drug intermediates for domestic and international markets. | vaasavaa.com |
Business activity
The main business activity of Vaasavaa Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vaasavaa Pharmaceuticals Private Limited, buy the company report.
Financials of Vaasavaa Pharmaceuticals Private Limited
FY 2025 filings availableVaasavaa Pharmaceuticals Private Limited reported revenue of ₹59.28 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 16% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.85 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.79 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vaasavaa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vaasavaa Pharmaceuticals Private Limited
Vaasavaa Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narasimha Rao Polavarapu | Director | 23 Jun 2003 | 23 Years 3 Months | Current |
| Murali Krishna Prasad Koneru | Director | 17 Jul 2000 | 26 Years 3 Months | Current |
| Sri Ram Dhanekula | Director | 04 Jul 2013 | 13 Years 3 Months | Current |
| Subbarao Chandraskhar Rao Movva | Director | 17 Jul 2000 | 26 Years 3 Months | Current |
Peer comparison
Vaasavaa Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cadchem Laboratories Limited | ₹59.73 Cr (FY 2024) | -13.0% | Chandigarh, India | |||
| Macsen Labs Limited | ₹59.7 Cr (FY 2025) | -9.0% | Udaipur, Rajasthan, India | |||
| Bhasya International Private Limited | ₹59.51 Cr (FY 2024) | 124.0% | Hyderabad, Telangana, India | |||
| Parb Pharmaceuticals Private Limited | ₹59.42 Cr (FY 2025) | 2461.0% | Dehradun, Uttarakhand, India | |||
| Vaasavaa Pharmaceuticals Private Limitedthis company | ₹59.28 Cr (FY 2025) | ₹1.79 Cr | 3% | 16.0% | 67 | Solapur, Maharashtra, India |
| Venus Chemicals and Drugs Private Limited | ₹59.13 Cr (FY 2025) | 66.0% | Hyderabad, Telangana, India | |||
| Vivachem Intermediates Private Limited | ₹59.12 Cr (FY 2025) | 84.0% | Raikot, Punjab, India | |||
| Keshava Organics Pvt Ltd | ₹58.68 Cr (FY 2025) | 11.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Vaasavaa Pharmaceuticals Private Limited, buy the company report.
Auditor
Vaasavaa Pharmaceuticals Private Limited is audited by ASHOK MADGUNDI AND COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHOK MADGUNDI AND COMPANY | FY 2023 | 100668W |
Shareholding
The shareholding of Vaasavaa Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vaasavaa Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2021 | 100496530 | Yes Bank Limited | ₹9.61 Cr | Open | |
| 28 Feb 2021 | 100429421 | Others | ₹29.98 Lakh | Satisfied | |
| 16 Jul 2020 | 100358500 | Others | ₹71.32 Lakh | Satisfied | |
| 28 Mar 2019 | 100255617 | Others | ₹25 Lakh | Satisfied | |
| 07 Oct 2013 | 10462868 | Andhra Bank | ₹20 Lakh | Satisfied |
To see the full charge records of Vaasavaa Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Vaasavaa Pharmaceuticals Private Limited has 4 court cases on record: 1 filed by Vaasavaa Pharmaceuticals, 3 filed against it. 1 case is pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed by the company against Discovery Laboratories P Ltd., Rep by Its M.Dir., Prasanth Manne and 2 others | Pending |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed against the company by Nine Labs Pvt., Ltd., Rep.By. A.Maheshwara Reddy | Disposed |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed against the company by Nine Labs Pvt., Ltd., Rep.By. A.Maheswara Reddy | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Cases SS) | Filed against the company by M-S.Super Chemicals | Disposed |
To see the full case history of Vaasavaa Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Vaasavaa Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 3 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier |
To see the full MSME payment records of Vaasavaa Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Vaasavaa Pharmaceuticals Private Limited has a workforce of 67 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Vaasavaa Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCV5177B1ZE | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vaasavaa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vaasavaa Pharmaceuticals Private Limited has 5 board changes on record since 2000: 4 appointments and 1 cessation. The latest: Sri Ram Dhanekula ceased to be Additional Director on 30 Sep 2014.
9 earlier events are in the company report.
Frequently asked questions
Vaasavaa Pharmaceuticals is an active private limited company based in Solapur, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 17 July 2000 (26+ years old) and is registered under CIN U24232PN2000PTC015122.
Vaasavaa Pharmaceuticals has 4 current directors:
- Narasimha Rao Polavarapu - Director
- Murali Krishna Prasad Koneru - Director
- Sri Ram Dhanekula - Director
- Subbarao Chandraskhar Rao Movva - Director
The latest financial statements of Vaasavaa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vaasavaa Pharmaceuticals is 27AABCV5177B1ZE, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Vaasavaa Pharmaceuticals is U24232PN2000PTC015122. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vaasavaa Pharmaceuticals has 4 court cases on record: 1 filed by the company and 3 filed against it. 1 is pending.
Vaasavaa Pharmaceuticals was incorporated on 17 July 2000, making it 26+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Vaasavaa Pharmaceuticals by revenue are Cadchem Laboratories Limited, Macsen Labs Limited, Bhasya International Private Limited, Parb Pharmaceuticals Private Limited, Venus Chemicals and Drugs Private Limited and 2 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sri Ram Dhanekula ceased to be Additional Director on 30 Sep 2014. Sri Ram Dhanekula was appointed as Director on 04 Jul 2013. Narasimha Rao Polavarapu was appointed as Director on 23 Jun 2003. Vaasavaa Pharmaceuticals has 5 board changes on record in total.
Vaasavaa Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 3 overdue payments to 1 micro and small supplier. The latest return was filed on 01 Nov 2019.
Vaasavaa Pharmaceuticals can be reached through the website vaasavaa.com. Its registered office is in Solapur, Maharashtra, India.
The registered office of Vaasavaa Pharmaceuticals is at Plot No C – 216 MIDC Chincholiarea, Solapur, Maharashtra, India – 413255.